A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression

Introduction: Muscle-specific kinase (MuSK)- myasthenia gravis (MG) is caused by pathogenic autoantibodies against MuSK that correlate with disease severity and are predominantly of the IgG4 subclass. The first-line treatment for MuSK-MG is general immunosuppression with corticosteroids, but the eff...

Full description

Bibliographic Details
Main Authors:	Koneczny, I, Mané-Damas, M, Zong, S, De Haas, S, Huda, S, van Kruining, D, Damoiseaux, J, De Rosa, A, Maestri, M, Guida, M, Molenaar, P, Van Damme, P, Fichtenbaum, A, Perkmann, T, De Baets, M, Lazaridis, K, Zouvelou, V, Tzartos, S, Ricciardi, R, Losen, M, Martinez-Martinez, P
Format:	Journal article
Language:	English
Published:	Frontiers Media 2024

A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression

Similar Items